0001055726-22-000011.txt : 20220301
0001055726-22-000011.hdr.sgml : 20220301
20220301184843
ACCESSION NUMBER: 0001055726-22-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220226
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Humeau Laurent
CENTRAL INDEX KEY: 0001770390
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 22700475
MAIL ADDRESS:
STREET 1: C/O INOVIO PHARMACEUTICALS, INC.
STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wf-form4_164617848636087.xml
FORM 4
X0306
4
2022-02-26
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001770390
Humeau Laurent
C/O INOVIO PHARMACEUTICALS, INC.
6769 MESA RIDGE RD.
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2022-02-26
4
M
0
22545
A
91132
D
Common Stock
2022-02-26
4
F
0
8545
3.22
D
82587
D
Restricted Stock Unit
2022-02-26
4
M
0
22545
0
D
Common Stock
22545.0
45088
D
Common Stock Option
3.22
2022-02-26
4
A
0
186000
0
A
2022-02-26
2032-02-26
Common Stock
186000.0
186000
D
Restricted Stock Unit
2022-02-26
4
A
0
138800
0
A
Common Stock
138800.0
138800
D
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
The vesting schedule for the 186,000 options is as follows: 46,500 shares vested on February 26, 2022; 46,500 shares will vest on February 26, 2023; 46,500 shares will vest on February 26, 2024; 46,500 shares will vest on February 26, 2025.
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 138,800 restricted stock units is as follows: 46,267 shares will vest on February 26, 2023; 46,267 shares will vest on February 26, 2024; 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
/s/ Laurent Humeau
2022-03-01